相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MicroRNA-155: A Master Regulator of Inflammation
Guruswamy Mahesh et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2019)
FOXO3a from the Nucleus to the Mitochondria: A Round Trip in Cellular Stress Response
Candida Fasano et al.
CELLS (2019)
Dual blockade of the PI3K/Akt/mTOR pathway inhibits posttransplant Epstein-Barr virus B cell lymphomas and promotes allograft survival
Adam X. Sang et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2019)
Enhancer Control of MicroRNA miR-155 Expression in Epstein-Barr Virus-Infected B Cells
C. David Wood et al.
JOURNAL OF VIROLOGY (2018)
Dynamics of Viral and Host Immune Cell MicroRNA Expression during Acute Infectious Mononucleosis
Vandana Kaul et al.
FRONTIERS IN MICROBIOLOGY (2018)
Critical role of FOXO3a in carcinogenesis
Ying Liu et al.
MOLECULAR CANCER (2018)
miR-155 in cancer drug resistance and as target for miRNA-based therapeutics
Recep Bayraktar et al.
CANCER AND METASTASIS REVIEWS (2018)
LMP1 signaling pathway activates IRF4 in latent EBV infection and a positive circuit between PI3K and Src is required
L. Wang et al.
ONCOGENE (2017)
The Immune Response to Epstein Barr Virus and Implications for Posttransplant Lymphoproliferative Disorder
Olivia M. Martinez et al.
TRANSPLANTATION (2017)
Methylation status and AP1 elements are involved in EBV-mediated miR-155 expression in EBV positive lymphoma cells
Qinyan Yin et al.
VIROLOGY (2016)
NKG2A-Expressing Natural Killer Cells Dominate the Response to Autologous Lymphoblastoid Cells Infected with Epstein-Barr Virus
Olivia Hatton et al.
FRONTIERS IN IMMUNOLOGY (2016)
Epstein-Barr Virus Modulates Host Cell MicroRNA-194 to Promote IL-10 Production and B Lymphoma Cell Survival
A. Harris-Arnold et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
MicroRNAs as master regulators of immune responses in transplant recipients
Vandana Kaul et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2015)
Epstein-Barr virus infection induces miR-21 in terminally differentiated malignant B cells
Eleni Anastasiadou et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Epigenetically altered miR-193b targets cyclin D1 in prostate cancer
Kirsi M. Kaukoniemi et al.
CANCER MEDICINE (2015)
Expression Profile of MicroRNAs in Epstein-Barr Virus-Infected AGS Gastric Carcinoma Cells
Aron R. Marquitz et al.
JOURNAL OF VIROLOGY (2014)
Epstein-Barr Virus EBNA1 Protein Regulates Viral Latency through Effects on let-7 MicroRNA and Dicer
Sheila Mansouri et al.
JOURNAL OF VIROLOGY (2014)
miR-193b directly targets STMN1 and uPA genes and suppresses tumor growth and metastasis in pancreatic cancer
Jian Li et al.
MOLECULAR MEDICINE REPORTS (2014)
Global burden of deaths from Epstein-Barr virus attributable malignancies 1990-2010
Gulfaraz Khan et al.
INFECTIOUS AGENTS AND CANCER (2014)
PI3K Inhibition Augments the Efficacy of Rapamycin in Suppressing Proliferation of Epstein-Barr Virus (EBV) plus B Cell Lymphomas
S. Furukawa et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Syk-Induced Phosphatidylinositol-3-Kinase Activation in EpsteinBarr Virus Posttransplant Lymphoproliferative Disorder
O. Hatton et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
The anti-inflammatory drug BAY 11-7082 suppresses the MyD88-dependent signalling network by targeting the ubiquitin system
Sam Strickson et al.
BIOCHEMICAL JOURNAL (2013)
Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation
Pascal Furet et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
microRNA-155 regulates cell proliferation and invasion by targeting FOXO3a in glioma
Nan Ling et al.
ONCOLOGY REPORTS (2013)
Quantitative Proteomics Reveals that miR-155 Regulates the PI3K-AKT Pathway in Diffuse Large B-Cell Lymphoma
Xin Huang et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Expression and prognosis of FOXO3a and HIF-1α in nasopharyngeal carcinoma
Zhu Shou et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
The Epstein-Barr Virus (EBV)-Induced Tumor Suppressor MicroRNA MiR-34a Is Growth Promoting in EBV-Infected B Cells
Eleonora Forte et al.
JOURNAL OF VIROLOGY (2012)
Differential regulation of miR-21 and miR-146a by Epstein-Barr virus-encoded EBNA2
P. Rosato et al.
LEUKEMIA (2012)
Epstein-Barr virus latent membrane protein-1 protects B-cell lymphoma from rituximab-induced apoptosis through miR-155-mediated Akt activation and up-regulation of Mcl-1
Joo Hyun Kim et al.
LEUKEMIA & LYMPHOMA (2012)
Src Kinase and Syk Activation Initiate PI3K Signaling by a Chimeric Latent Membrane Protein 1 in Epstein-Barr Virus (EBV) plus B Cell Lymphomas
Olivia Hatton et al.
PLOS ONE (2012)
The Viral and Cellular MicroRNA Targetome in Lymphoblastoid Cell Lines
Rebecca L. Skalsky et al.
PLOS PATHOGENS (2012)
miR-193b Regulates Mcl-1 in Melanoma
Jiamin Chen et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
CAL-101, a p110δ selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability
Brian J. Lannutti et al.
BLOOD (2011)
Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses
Kennosuke Karube et al.
BLOOD (2011)
Syk Activation of Phosphatidylinositol 3-Kinase/Akt Prevents HtrA2-dependent Loss of X-linked Inhibitor of Apoptosis Protein (XIAP) to Promote Survival of Epstein-Barr Virus plus (EBV plus ) B Cell Lymphomas
Olivia Hatton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Oncogenic IRFs Provide a Survival Advantage for Epstein-Barr Virus- or Human T-Cell Leukemia Virus Type 1-Transformed Cells through Induction of BIC Expression
Ling Wang et al.
JOURNAL OF VIROLOGY (2011)
Canonical NF-κB Activation Is Essential for Epstein-Barr Virus Latent Membrane Protein 1 TES2/CTAR2 Gene Regulation
Benjamin E. Gewurz et al.
JOURNAL OF VIROLOGY (2011)
Akt-FOXO3a signaling axis dysregulation in human oral squamous cell carcinoma and potent efficacy of FOXO3a-targeted gene therapy
Liang Fang et al.
ORAL ONCOLOGY (2011)
Upregulation of MiR-155 in Nasopharyngeal Carcinoma is Partly Driven by LMP1 and LMP2A and Downregulates a Negative Prognostic Marker JMJD1A
Zi-Ming Du et al.
PLOS ONE (2011)
MicroRNA-193b Represses Cell Proliferation and Regulates Cyclin D1 in Melanoma
Jiamin Chen et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Drugging the PI3 Kinome: From Chemical Tools to Drugs in the Clinic
Paul Workman et al.
CANCER RESEARCH (2010)
miR-193b is an epigenetically regulated putative tumor suppressor in prostate cancer
Hanna E. Rauhala et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Clinical and biological significance of forkhead class box O 3a expression in glioma: mediation of glioma malignancy by transcriptional regulation of p27kip1
Jinlong Shi et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Virally Induced Cellular MicroRNA miR-155 Plays a Key Role in B-Cell Immortalization by Epstein-Barr Virus
Sarah D. Linnstaedt et al.
JOURNAL OF VIROLOGY (2010)
Upregulation of Id1 by Epstein-Barr Virus-encoded LMP1 confers resistance to TGFβ-mediated growth inhibition
Angela K. F. Lo et al.
MOLECULAR CANCER (2010)
Activation of the JAK/STAT Pathway in Epstein Barr Virus+-Associated Posttransplant Lymphoproliferative Disease: Role of Interferon-γ
M. Vaysberg et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
miR-155 gene: A typical multifunctional microRNA
Isabella Faraoni et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
Age-related Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients
Naoko Asano et al.
BLOOD (2009)
Low expression of Foxo3a is Associated with Poor Prognosis in Ovarian Cancer Patients
Min Fei et al.
CANCER INVESTIGATION (2009)
Immunomodulator agent-related lymphoproliferative disorders
Robert P. Hasserjian et al.
MODERN PATHOLOGY (2009)
Spontaneous remission of methotrexate-associated lymphoproliferative disorders after discontinuation of immunosuppressive treatment for autoimmune disease. Review of the literature
Rita Rizzi et al.
MEDICAL ONCOLOGY (2009)
Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer
X-F Li et al.
ONCOGENE (2009)
Inositol phosphatase SHIP1 is a primary target of miR-155
Ryan M. O'Connell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Latent membrane protein-1 of Epstein-Barr virus induces the expression of B-cell integration cluster, a precursor form of microRNA-155, in B lymphoma cell lines
Nur Rahadiani et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Tumor-derived Variants of Epstein-Barr Virus Latent Membrane Protein 1 Induce Sustained Erk Activation and c-Fos
Maria Vaysberg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer
Adrian J. Folkes et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Epstein-Barr virus latent membrane protein 1 represses DNA repair through the PI3K/Akt/FOX03a pathway in human epithelial cells
Yi-Ren Chen et al.
JOURNAL OF VIROLOGY (2008)
Epstein-Barr Virus-Induced miR-155 Attenuates NF-κB Signaling and Stabilizes Latent Virus Persistence
Fang Lu et al.
JOURNAL OF VIROLOGY (2008)
MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways
Qinyan Yin et al.
JOURNAL OF VIROLOGY (2008)
ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation
Jer-Yen Yang et al.
NATURE CELL BIOLOGY (2008)
Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-κB pathway
Graziana Gatto et al.
NUCLEIC ACIDS RESEARCH (2008)
Epstein-Barr virus growth/latency III program alters cellular microRNA expression
Jennifer E. Cameron et al.
VIROLOGY (2008)
LMP1 signaling can replace CD40 signaling in B cells in vivo and has unique features of inducing class-switch recombination to IgG1
Julia Rastelli et al.
BLOOD (2008)
Forkhead box transcription factor FOXO3a suppresses estrogen-dependent breast cancer cell proliferation and tumorigenesis
Yiyu Zou et al.
BREAST CANCER RESEARCH (2008)
Latent membrane protein 1 of EBV activates phosphatidylinositol 3-kinase to induce production of IL-10
Stacie L. Lambert et al.
JOURNAL OF IMMUNOLOGY (2007)
Structural variability of the carboxy-terminus of Epstein-Barr virus encoded latent membrane protein 1 gene in Hodgkin's lymphomas
Deisy M. Guiretti et al.
JOURNAL OF MEDICAL VIROLOGY (2007)
Age-related EBV-Associated B-Cell Lymphoproliferative disorders constitute a distinct clinicopathologic group: A study of 96 patients
Takashi Oyama et al.
CLINICAL CANCER RESEARCH (2007)
Subtractive hybridization identifies novel differentially expressed ncRNA species in EBV-infected human B cells
Jan Mrazek et al.
NUCLEIC ACIDS RESEARCH (2007)
LMP1 strain variants: Biological and molecular properties
Bernardo A. Mainou et al.
JOURNAL OF VIROLOGY (2006)
Epstein-Barr virus LMP1 inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome
HC Chuang et al.
BLOOD (2005)
Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K
BA Mainou et al.
ONCOGENE (2005)
Identification of virus-encoded microRNAs
S Pfeffer et al.
SCIENCE (2004)
IκB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a
MCT Hu et al.
CELL (2004)
Two carboxyl-terminal activation regions of Epstein-Barr virus latent membrane protein 1 activate NF-κB through distinct signaling pathways in fibroblast cell lines
N Saito et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Epstein-Barr virus latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase/Akt pathway to promote cell survival and induce actin filament remodeling
CW Dawson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Epstein-Barr virus LMP-1 natural sequence variants differ in their potential to activate cellular signaling pathways
CA Fielding et al.
JOURNAL OF VIROLOGY (2001)
The Epstein-Barr virus latent membrane protein 1 induces interleukin-10 in Burkitt's lymphoma cells but not in Hodgkin's cells involving the p38/SAPK2 pathway
M Vockerodt et al.
VIROLOGY (2001)
Identification of functional differences between prototype Epstein-Barr virus-encoded LMP1 and a nasopharyngeal carcinoma-derived LMP1 in human epithelial cells
CW Dawson et al.
VIROLOGY (2000)
分享论文
